A recent Bloomberg Law article, “PBMs Urge DOL to Withdraw Rule on Drug Intermediary Profits,” spotlights the growing debate over a Department of Labor proposal that would expand transparency requirements for pharmacy benefit managers. As industry groups push back and employers seek greater insight into drug pricing, Groom Law Group principal Amber Rivers provides perspective on how the rule fits within the broader regulatory framework.
“The timing of the proposal and the legislation indicates a strong likelihood that the department had some inclination that the legislation was moving,” Rivers said, adding that “they may be of the view they have independent authority to move forward.” Her comments hint at the key legal and policy questions shaping the rule’s future.
To read the article, click here.
